Perx Health is a digital care company building high-engagement digital care programs for high-risk chronic conditions patients. Our proprietary behavioral science delivers results for all types of patients regardless of their level of health literacy, socioeconomic status and/or complex co-morbidity. Perx is proven to improve clinical health outcomes in peer-reviewed research and generate 6x ROI of healthcare savings for our large enterprise customers.

The Propeller Digital Therapeutic Platform

Propeller’s FDA-cleared digital therapeutic platform consists of Bluetooth-enabled sensors, a digital patient experience through mobile app or web portal, a clinician insights portal for remote monitoring, plus tailored patient support through virtual coaching. These components seamlessly integrate with one another to improve health outcomes for patients, and in turn, drive measurable clinical and business outcomes for healthcare organizations. Here’s how it works:

1. PropellerConnect™ Sensors & Data Connectivity: Propeller sensors capture unique signals that passively record events, such as medication usage or respiration, and transmit data to Propeller via Bluetooth or hub connection. Sensors are compatible with more than 80% of inhaled medications on the U.S. market, including medications for MDI, Respimat®, Diskus®, Ellipta®, and Symbicort® inhalers.*
2. MyPropeller™ Patient App & Portal: Sensor data is sent to the Propeller mobile app or online portal, empowering patients to learn about their breathing and triggers while delivering personalized, motivating journeys that build healthy habits.
3. PropellerInsight™ Clinical Decision Support & Analytics: Via an EHR integration or our Clinician Portal, care teams can remotely monitor patients’ medication use and view on-demand reports to gain a clearer understanding of disease control status, symptoms, and triggers. These insights help inform clinical decisions and treatment plans, and enable proactive identification of patients who may be at a greater risk for an exacerbation and require timely clinical intervention.
4. PropellerCare™ Support and Coaching: Propeller’s patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing.

Propeller Health Solutions

Propeller configures its digital therapeutic platform into a variety of solutions that help healthcare and life sciences organizations meet their goals while navigating the shift to value-based care.

• For Independent Physician Groups: Remote therapeutic monitoring programs to enhance care for eligible chronic patients
• For Hospitals and Health Systems: Digital health programs for select clinics, target populations, or systemwide; integration into a service line/specialty for population health management
• For Payers and Pharmacy Benefits Managers: Integration of digital health programs into existing care management or population health initiatives
• For Life Sciences Organizations: Integration or co-packaging of digital companion (i.e., sensor, app, support) with connected drug delivery devices such as inhalers to support clinical trials, medication adherence, and biologics

---

*Respimat is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc. Diskus and Ellipta are registered trademarks of the GlaxoSmithKline group of companies. Symbicort is a registered trademark of the AstraZeneca group of companies.

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, health systems, payers, pharmaceutical companies, and other healthcare and life sciences organizations.

The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support, and secure access to clinical data for provider monitoring. Our precision approach motivates behavior change and tracks patient adherence that enables medication optimization, helping predict costly exacerbations. We set the scientific standard in digital-first chronic respiratory care through our peer-reviewed research demonstrating improved quality of life and clinical outcomes while lowering healthcare costs.

As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

Perx’s core value proposition is the ability to attract, engage and serve healthcare’s high-risk, highest-cost patient groups through our unique approach. Our completely customizable and modular solution can map into internal tools and has features and outcomes beyond any homegrown tool:

• Engaging Experience: a variety of extrinsic and intrinsic motivators (gamification, extrinsic rewards, community support and challenges) to engage individuals in a personalized way. Participants in our programs use Perx 3-4 times a day, with daily engagement (72% of monthly activity) equal to mobile consumer applications Facebook and Twitter (66% and 46% respectively).
• Comprehensive and configurable condition support: catering to all conditions and comorbidities with treatment plan management across medication schedules, exercise plans, appointment scheduling, measurement taking and health tasks. Our platform’s flexible modules can be configured to match the needs of our commercial partners.
• Clinically validated health outcomes: the University of Technology Sydney demonstrated in peer-reviewed research that Perx sustained long-term treatment adherence of 96% over six months, and in a randomized control trial with the University of Sydney, Perx patients demonstrated improved clinical bio-markers (HbA1c and cholesterol) versus standard care over 12 months.
• Real-time verified data capture: validation of treatment management in real-time using clinical trial standard methods such as mobile direct observation of therapy (mDOT), collection of patient-reported experience and outcome measures (PROMs), and any condition specific surveys to validate and improve health outcomes. These real-world evidence capabilities are built into the platform to track program adoption, veteran satisfaction and report relevant health outcomes.

Perx’s digital CDMPs are designed to attract, engage and serve healthcare’s high-risk, highest-cost patient groups with a flexible, single solution, personalizing the experience through systematic ‘precision’ behavioral change while integrating with clinical care. We offer high-risk patients a materially different value proposition than our competitors:

• Gamified treatment interventions focus on gamification only, inadvertently treating high-risk individuals as a homogeneous population. Perx uses a range of behavioral strategies to personalise the experience, drive higher engagement, and enroll a more diverse cohort of patients.
• Digital CDMPs aim to control primary risk factors (blood pressure, glucose control or cholesterol) by modifying key risk behaviors (smoking, weight management, exercise, alcohol consumption). Unsuitable for high-risk patients, these programs focus on treating single conditions, are reliant on education and health coaching, and operate independently from clinical care teams.
• Wellness solutions focus on disease prevention by providing general health, wellbeing and lifestyle interventions (exercise, nutrition, mental wellbeing and health check-ups). While attractive to health-conscious populations, these solutions fail to engage low socioeconomic, health illiterate patients managing complex comorbidities.
• Patient access solutions pursue the mass-market and focus on patient acquisition (regardless of condition or health-risk). Solutions are monetised by selling data or providing patient access for marketing purposes, with little-to-no independently published research demonstrating behaviour change or outcomes. 

To learn about how Propeller differentiates from other options in this space, please reach out to info@propellerhealth.com. 

As a leading precision digital health company, Propeller Health differs from others in the industry in that:  

• Our 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market – and our capabilities go far beyond respiratory care.
• We have conducted 80+ commercial programs and research studies, and a body of research no other digital health company can match: more than 150 peer-reviewed publications and abstracts.
• Our parent company has decades of experience bringing specialized medical devices to market in more than 140 countries. Together, our regulatory expertise, logistics support, engineering and component sourcing knowledge is unmatched.
• We have unique experience partnering with and unifying value for stakeholders across the healthcare ecosystem: independent clinics, hospitals and health systems, payers and PBMs, pharmaceutical and life sciences companies, as well as patients and clinicians. 

---

Our FDA-cleared digital therapeutic platform stands apart from other digital health solutions in that: 

• It is used by a broad spectrum of patients from pediatric (asthma) to elderly (COPD), and is proven effective in engaging underserved and vulnerable patient populations (Medicaid, Medicare). 
• It engages patients with COPD — an often difficult to engage patient population — earlier in their care (stages 1 and 2). For patients whose conditions continue to progress, they can receive care in later stages (3 and 4) with solutions from our parent company, ResMed.